Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2020

Sep 24, 2020

33298_dirs_2020-09-24_18cd64f5-32d2-4177-9a9d-2c93ed679b2f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-09-23

Reporting Person: Galluppi Stefan (Director, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-23 Common Stock, par value $0.01 S 401000 $1.00 Disposed 749000 Indirect

Footnotes

F1: Mr. Galluppi has sole voting and dispositive power over American Nutra Tech, LLC